Transgene and Randox to develop oncolytic treatment for solid tumours

Transgene has a partnered with in-vitro diagnostics company Randox to combine their technologies and develop multifunctional oncolytic immunotherapies.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news